ישראל - עברית - Ministry of Health

תרופארם שיווק 1985 בע"מ - רופא - שיקום נשימתי

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - pegaspargase - אבקה להמסה להזרקה\אינפוזיה - pegaspargase 3750 u/vial - pegaspargase

ישראל - עברית - Ministry of Health

"ס. י. ר. א. מ. בע""מ" - אחות - שתלים וחבישות המכילים חומר מן החי

ישראל - עברית - Ministry of Health

ס. י. ר. א. מ. בע"מ - אחות - שתלים וחבישות המכילים חומר מן החי

ישראל - עברית - Ministry of Health

מטי ציוד רפואי בע"מ - רופא - מסמר לקיבוע גפיים בילדים עם אוסטאוגנסיס אימפרפקטה

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - peginterferon alfa 2a 135 mcg / 0.5 ml - solution for injection - peginterferon alfa-2a - chronic hepatitis b: pegasys is indicated for the treatment of both hbeag- positive and hbeag -negative chronic hepatitis b in non-cirrhotic and cirrhotic adult patients with compensated liver disease and evidence of viral replication and liver inflammation.chronic hepatitis c: pegasys is indicated for the treatment of chronic hepatitis c in adult patients who are positive for serum hcv-rna including patients with compensated cirrhosis and/or co-infected with clinically stable hiv. the optimal way to use pegasys in patients with chronic hepatitis c is in combination with ribavirin. the combination of pegasys and ribavirin is indicated in naive patients and patients who have failed previous treatment with interferon alpha (pegylated or non-pegylated ) alone or in combination therapy with ribavirin. monotherapy is indicated mainly in case of intolerance or contraindication to ribavirin.

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - peginterferon alfa 2a 180 mcg / 0.5 ml - solution for injection - peginterferon alfa-2a - chronic hepatitis b: pegasys is indicated for the treatment of both hbeag- positive and hbeag -negative chronic hepatitis b in non-cirrhotic and cirrhotic adult patients with compensated liver disease and evidence of viral replication and liver inflammation.chronic hepatitis c: pegasys is indicated for the treatment of chronic hepatitis c in adult patients who are positive for serum hcv-rna including patients with compensated cirrhosis and/or co-infected with clinically stable hiv. the optimal way to use pegasys in patients with chronic hepatitis c is in combination with ribavirin. the combination of pegasys and ribavirin is indicated in naive patients and patients who have failed previous treatment with interferon alpha (pegylated or non-pegylated ) alone or in combination therapy with ribavirin. monotherapy is indicated mainly in case of intolerance or contraindication to ribavirin.

ישראל - עברית - Ministry of Health

becton dickinson (bd) israel ltd., israel - chlorhexidine gluconate; isopropyl alcohol - isopropyl alcohol 0.7 ml / 1 ml; chlorhexidine gluconate 20 mg / 1 ml - chlorhexidine, combinations

ישראל - עברית - Ministry of Health

becton dickinson (bd) israel ltd., israel - chlorhexidine gluconate; isopropyl alcohol - isopropyl alcohol 0.7 ml/ml; chlorhexidine gluconate 20 mg/ml - chlorhexidine, combinations